IgG2 is an antibody subclass critical for defending against encapsulated bacteria like pneumococci. It is measured to evaluate immune competence.
IgG2 is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
IgG2 is commonly relevant when fatigue raises questions about iron status, storage depletion, or anemia-related complaints. It can provide an important clue, but it rarely explains the full symptom picture by itself.
IgG2 does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
IgG2 is one of four subclasses of immunoglobulin G (IgG), accounting for about 20–30% of total IgG in adults. It plays a key role in the immune response against bacteria that have a polysaccharide capsule, such as Streptococcus pneumoniae and Haemophilus influenzae. Because IgG2 antibodies are particularly directed against carbohydrate antigens, a deficiency can raise susceptibility to certain respiratory and bloodstream infections.
IgG2 levels are usually measured alongside other immunoglobulin subclasses when a humoral immunodeficiency is suspected, in cases of recurrent sinopulmonary infections, or during the workup of a low total IgG.
An IgG2 value below the lab-dependent reference range (typically less than 150 mg/dL [1.5 g/L] in adults) may suggest an IgG2 subclass deficiency. This can increase vulnerability to bacterial infections, especially those caused by encapsulated organisms. Low IgG2 can occur as an isolated deficiency, as part of common variable immunodeficiency (CVID), or alongside broader immunoglobulin deficits. Transiently low levels are normal in young children but may be clinically significant if persistent beyond infancy.
An IgG2 value above the lab-dependent reference range (typically above 640 mg/dL [6.4 g/L] in adults) is less commonly a primary concern. It may be seen in chronic infections that drive a sustained IgG2 response against polysaccharide antigens, in certain autoimmune or inflammatory conditions such as IgG4-related disease, or in monoclonal gammopathies where a specific plasma cell clone overproduces the antibody. Such elevations are interpreted together with other immunoglobulin fractions and clinical findings.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
IgG2 is commonly relevant when fatigue raises questions about iron status, storage depletion, or anemia-related complaints. It can provide an important clue, but it rarely explains the full symptom picture by itself.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Immunoglobulin G Subclass 2 (IgG2) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
Typical adult reference ranges are lab-dependent but often fall between 150 and 640 mg/dL (1.5–6.4 g/L). Because ranges vary by method and population, results should be compared to the laboratory’s own reference interval. Pediatric ranges differ and change with age.
A low IgG2 may indicate an IgG2 subclass deficiency, which can impair the body’s ability to fight certain bacterial infections. It may be an isolated finding or part of a broader immunodeficiency such as CVID. Recurrent sinopulmonary infections often prompt this test.
Elevated IgG2 can result from chronic antigenic stimulation, for example due to persistent bacterial infections. It may also be seen in autoimmune conditions or monoclonal gammopathies. In most cases, a high value alone is not diagnostic and is evaluated in context.
Yes, IgG2 levels normally increase throughout childhood and reach adult levels by adolescence. Transiently low levels in infants are common and do not always indicate a permanent immunodeficiency. Age-adjusted reference ranges are essential for interpreting pediatric results.
IgG2 does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
For many fatigue-related, inflammatory, hormonal, or recovery-linked markers, interpretation becomes stronger when symptoms, exertion response, and daily function are considered together.
IgG2 is rarely meaningful in isolation when fatigue, brain fog, or unstable capacity are central. The fatigue hub provides the broader lab-and-symptom context.
If symptoms worsen after activity with a delay, PEM often explains more than an isolated lab value alone.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
These references support the information presented on this page.
https://www.imd-berlin.de/spezielle-kompetenzen/immundefekte/untersuchungsverfahren/immunglobulin-und-igg-subklassenanalyse
imd-berlin.de
https://www.netdoktor.de/laborwerte/immunglobulin/g/
netdoktor.de
https://www.gesundheit.gv.at/labor/laborwerte/immunsystem/igg.html
gesundheit.gv.at
https://www.dsai.de/fileadmin/user_files/publikationen/broschueren_und_flyer/flyer_krankheiten_igd.pdf
dsai.de
https://flexikon.doccheck.com/de/Immunglobulin_G2
flexikon.doccheck.com
https://flexikon.doccheck.com/de/IgG-Subklassenanalyse
flexikon.doccheck.com
https://gpnotebook.com/de/pages/infektiologie/igg-zusammenfassung-und-ursachen-fur-erhohte-und-erniedrigte-werte
gpnotebook.com
https://www.laborchemnitz.de/leistungen/leistungsverzeichnis/detail/leistung/beta-2-glykoprotein-i-antikoerper-typ-igg-igm
laborchemnitz.de
https://pubmed.ncbi.nlm.nih.gov/3292083/
pubmed.ncbi.nlm.nih.gov
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
